Clinical Trials
2 trialsNCT06116318 2026-05-13
A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Withdrawn
NCT07498465 2026-05-05
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia
Children's Oncology Group
Phase 1 Withdrawn